Compare WYFI & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WYFI | CMPS |
|---|---|---|
| Founded | 2023 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 806.5M | 662.5M |
| IPO Year | 2025 | 2020 |
| Metric | WYFI | CMPS |
|---|---|---|
| Price | $19.56 | $7.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $34.38 | $16.43 |
| AVG Volume (30 Days) | 932.7K | ★ 1.4M |
| Earning Date | 03-09-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,202,034.00 | N/A |
| Revenue This Year | $64.64 | N/A |
| Revenue Next Year | $129.13 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.91 | $2.25 |
| 52 Week High | $40.75 | $8.20 |
| Indicator | WYFI | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.12 |
| Support Level | N/A | $6.91 |
| Resistance Level | N/A | $7.75 |
| Average True Range (ATR) | 0.00 | 0.53 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 0.00 | 45.59 |
Whitefiber Inc is a provider of artificial intelligence infrastructure solutions. The company owns high-performance computing data centers and provide cloud-based HPC graphics processing units services, which it terms cloud services, for customers such as AI application and machine learning developers. Its Tier-3 data centers provide hosting and colocation services. Its cloud services support generative AI workstreams, especially training and inference. It has two reportable segments: cloud services and colocation services. The cloud services segment generates revenue from providing high performance computing services to support generative AI workstreams. Colocation services generate revenue by providing customers with physical space, power and cooling within the data center facility.
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.